The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A dual institution real-world study of avelumab for advanced Merkel cell carcinoma.
 
David Michael Miller
Stock and Other Ownership Interests - Checkpoint Therapeutics
Consulting or Advisory Role - Castle Biosciences; Checkpoint Therapeutics; Merck Sharp & Dohme; Pfizer/EMD Serono; Regeneron; Sanofi/Regeneron
Research Funding - Incyte
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer; Regeneron; Sanofi/Aventis
 
Kayla Wright
No Relationships to Disclose
 
Ann W. Silk
Consulting or Advisory Role - Instil Bio; Signatera
Research Funding - Biohaven Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Morphogenesis (Inst); Replimune (Inst); Shattuck Labs (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Manisha Thakuria
No Relationships to Disclose
 
Sophia Shalhout
Patents, Royalties, Other Intellectual Property - YAP TEAD small molecule inhibitors and uses thereof